The health insurer does not fully reimburse ONTOZRY® (12.5mg/25mg, 50 mg, 100 mg, 150mg). The producer of this medicine has...
Reimbursement Scheme Jardiance® (empagliflozin)10 mg for patients with HFpEF (Ejection fraction>40%)
The health insurer does not yet fully reimburse Jardiance (Empagliflozin)® 10 mg for the treatment of HFpEF (Ejection fraction...
Recently also Acecort® 2 and 3 mg tablets have been registered. The health insurer will not reimburse the cost in full. The...
Renewal reimbursement scheme Forxiga® (dapagliflozine) 10 mg and Xigduo (dapagliflozine & metformine HCI) 5 mg
The Reimbursement Solution TerugBetaalRegeling (TBR) of Forxiga® (dapagliflozine) 10 mg and Xigduo (dapagliflozine & metformine...
As of December 1, 2021, a Personal Contribution for Tecfidera is no longer required. Health insurers will once again fully...
Select your medicine
- Forxiga® - Diabetes
- Forxiga® - HFpEF
- Jardiance® - HF
- Jardiance® - Chronic Kidney Disease
- Metoject Pen®
- Veltassa ®
- Latest updates on Medicines
Check your medicine expenses
Quickly check the maximum contribution you have to pay for your medicine